The Institute of Cardiovascular Sciences, Peking University, Beijing, ChinaCardiovascular metabolism; Lipid metabolism; Cardiovascular and cerebrovascular research; Cardiovascular translational medicine
Center for Studies and Research in Cognitive Neuroscience, Department of Psychology, University of Bologna, Bologna, ItalyTMS; Skin conductance; Heart rate variability; Fear conditioning; Learning; Neuropsychology; Anxiety; Depression; Working memory; PTSD; Skin conductance responses; Psychophysiology; Error-related negativity; EEG; tDCS; Alzheimer’s disease; PIT; Stress-related disorders; Parkinson disease; Resilience; Memory; Neurologic patients; Cognitive decisions; fMRI; Translational and molecular psychiatry
Department of Chemistry, Cleveland State University, Cleveland, United StatesCancer Chemotherapy; DNA Damaging Agents; DNA Polymerases; Nucleoside Analogs; DNA Repair; DNA Damage Response; Leukemia; Glioblastoma Multiforme
Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, ChinaImmune kidney disease; Diabetes nephropathy; Nephritis; Chronic kidney disease; Renal insufficiency
Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, ChinaGenomics; Proteomics; Drug repurposing; Bioinformatics; Next-generation sequencing; Cancer biomarker; Evidence-based medicine; Extracellular vesicles; MicroRNA; Molecular diagnostics; Non-coding RNAs; Nasopharyngeal carcinoma; Non-small cell lung cancer
Dr. William Cho is a biomedical scientist at the Department of Clinical Oncology, Queen Elizabeth Hospital in Hong Kong. With a strong background in cancer biomarker discovery and translational research, Dr. Cho has published extensively in peer-reviewed journals. His research interests include genomics, proteomics, and liquid biopsy in oncology. He actively serves on editorial boards and is a frequent reviewer for international scientific journals.
Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, CanadaPharmacokinetics; Drug Delivery; Pharmaceutics; Pharmacology; Toxicology
Dr. Neal M. Davies received his undergraduate degree in Pharmacy from the University of Alberta in 1991. In 1996, he completed his Ph.D. in pharmaceutical sciences, specializing in pharmacokinetics, at the University of Alberta. From 1995 to 1998, he undertook postdoctoral training in pharmacology and toxicology at the University of Calgary. He then joined the University of Sydney as a lecturer in 1998. In 2002, he returned to North America to join the Washington State University’s (WSU) College of Pharmacy as an academic staff member, where he has held the positions of Director of the Pharmaceutical Sciences Graduate Program, as well as Director of Professional and Undergraduate Research and Director of Summer Undergraduate Research Fellowship program. He has been active on numerous university-wide committees, including service as a member of WSU’s Faculty Senate and Chair of the Institutional Animal Care and Use Committe. From 2011-2016 he was Dean of the Faculty of Pharmacy at the University of Manitoba. Under his direction he has been involved in several administrative and operational initiatives including: strategic planning, faculty accreditation review processes; and development of a first professional degree in Pharmacy (PharmD) program. He played key roles in faculty and graduate student recruitment and success and development of Pharmaceutical Analysis Laboratory (PAL). Throughout his career, Dr. Davies has strived to maintain the highest standard of teaching and research, and his achievements in both areas have been recognized through numerous awards and honours including several from the United States Pharmacopeia and the Canadian Society of Pharmaceutical Sciences. He has taught at the undergraduate and graduate levels, and has an ongoing and significant commitment toward graduate supervision and training. He has been at the forefront of the use of technology in the classroom, has re-engineered curricular content and maintained a high standard in student mentoring. Dr. Davies also maintains an active and highly collaborative externally-funded research program, focused on pharmacokinetics and drug delivery as well as basic and clinical pharmaceutical sciences which have attracted National Institutes of Health and Industry funds. He holds five patent applications and has disseminated his work broadly through numerous journal publications, a book and book chapters, abstracts, and invited conference presentations. He has ~8000 citations and an H-index >50. Dr. Davies has been a registered pharmacist with the Alberta College of Pharmacists since 1991. He is active in numerous professional organizations/associations, including the Canadian Society of Pharmaceutical Sciences and the American Association of Pharmaceutical Scientists, and serves as a reviewer and on the editorial board of several pharmaceutical and pharmacological science journals. Over the past decade Dr. Davies has also been heavily involved in pharmacy education research including curriculum mapping, interprofessional education, online teaching, and implementing expanded scopes of practice programs. On September 1, 2016 Dr. Davies commenced his term as Dean and Professor in the Faculty of Pharmacy & Pharmaceutical Sciences at the University of Alberta.
Department of Pathology, National University of Singapore, SingaporeCancer Immunotherapy; Targeted Therapy; Cancer Vaccine; Cancer Genome; cfDNA Methylome and Cancer Screening
Research Assistant Professor in the field of Pathology.
The research interests of the applicant focus on two critical areas in cancer research: developing innovative therapeutic approaches to overcome resistance to cancer immunotherapy; and identifying genetic and epigenetic abnormalities in cancers and pre-cancers. He has authored 71 manuscripts in international journals, over half of them were published in journals with impact factor >10. He also served as an invited ad hoc reviewer and reviewed over 440 manuscripts for 131 international journals. Over the past two years, he has successfully secured more than 2.2 million SGD in research funding as the Principal Investigator (PI), and 3.5 million SGD as Co-Investigator and Collaborator. He also contributes as a Team Principal Investigator to a large CRP (Competitive Research Programme) grant from NRF. He was the recipient of the prestigious Lee Kuan Yew Postdoctoral Fellowship and the Year 2021 Gilead Research Scholars Award (Hematology and Oncology).
Innovation Center of NanoMedicine (iCONM), Kawasaki Institute of Industrial Promotion, 3-25-14 Tonomachi, Kawasaki-ku 210-0821, Kawasaki, JapanBiomaterials; Drug Delivery Systems; Targeted Delivery; Stimuli-Sensitive Nanomedicine; Nucleic Acid Therapeutics; Protein Drugs, Biologics
Coordinator of the International Head and Neck Scientific Group, Padua, ItalyHead and Neck Cancer; Neuroendocrine Neoplasms of the Head and Neck; Distant Metastases from Head and Neck Cancer
He has been honored with several distinctions from professional ENT Societies including two Presidential Citations from the American Laryngological Associationfor his contributions made to the field of laryngology and the association. He has been appointed as the International Liaison for Corresponding Fellows of the American Laryngological Association. He is also a Fellowship External Examiner in Otorhinolaryngology at the Royal College of Surgeons in Ireland.
Department of Experimental and Clinical Medicine, University of Florence, ItalymCRPC; mCSPC; Biomarkers for Prostate Cancer; Treatment for Prostate Cancer
Dr. Edoardo Francini is a clinical researcher at the University of Florence, Italy. His research focuses on the treatment and management of genitourinary cancers, particularly prostate and bladder cancer, with a strong emphasis on immunotherapy and clinical trial development.
Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, ItalyBiochemistry and molecular biology of transglutaminases; Neurodegeneration; Neuroinflammation
Department of Population and Public Health Sciences, Division of Epidemiology and Genetics, Keck School of Medicine of USC, Los Angeles, United StatesStatistical Genetics; GWAS; Meta-analysis; Gene-environment interaction; Mendelian Randomization; Cardiovascular disease; Mendelian Randomization
Children's Hospital and School of Medicine, China Medical University, TaiChung, Taiwan province of ChinaStructural/congenital cardiovascular disease; Kawasaki Disease; Ultasound/echocardiography; Digital medicine; Interventional cardiovascular disease treatment; Hypertension; Metabolic heart disease and cardiovascular health promotion; Pediatric intensive care; Pediatric thoracic medicine; Perinatal fetal and neonatal medicine
Laboratory of Cancer Signaling, Division of Cellular and Molecular Research, National Cancer Centre Singapore and the Cancer and Stem Cell Program, Duke-NUS Medical School, SingaporeRAS/RAF/MEK/ERK Signaling; Protein kinase and protein phosphorylation; Targeted therapy and Drug resistance; Cancer biology and Immunology
Department of Gynecology and Obstetrics, Johns Hopkins University, School of Medicine, 720 Rutland Ave, Ross Research Building, Room 624, Baltimore, MD 21205, USANutraceuticals; Dietary products; Natural compounds; Reproductive disorders; Cancers; Inflammation and fibrosis; Uterine fibroids; Growth factor and proges-terone signaling; Small molecule inhibitors
Laboratory of Physiological Genetics of Institute of Biochemistry and Genetics - Subdivision of the Ufa Federal Research Centre of the Russian Academy of Sciences, Department of Biology, Bashkir State Medical University, Russian FederationMolecular mechanisms of complex traits; Genetic factors of chronic obstructive pulmonary disease; Genetic factors of longevity; Genetic factors of type 2 diabetes mellitus; Genetics; Cell biology
Department of Clinical Research, University of Southern Denmark (SDU), Odense, Denmark; Centre for Clinical Implementation of Capsule Endoscopy (CICA) , Store Adenomer Tidlige Cancere Centre (SATC-C), Svendborg, DenmarkCapsule Endoscopy; Colonoscopy; Microscopic colitis; Double-Balloon Enteroscopy; Colon Cancer; Endoscopy
Heart and Vascular Institute, Hershey Medical Center Pennsylvania State University, Hershey, United StatesCardiovascular diseases; Immunology; Cell biology and physiology; Molecular biology; Heart failure; Myocardial infarction
Dr. Vinay Kumar holds a master's degree in biotechnology from Himachal Pradesh University, Shimla, India, as well as a PhD in Molecular Biology and Genetic Engineering from Jawaharlal Nehru University, New Delhi, India. Presently at Pennsylvania State University, he conducts thorough studies of dysregulated innate and adaptive immunological networks and their function in modulating the pathophysiology of myocardial infarction (MI) and chronic heart failure (HF).
Dr. Kumar is especially interested in determining the function of T-cell subsets and the time-dependent phenotypic changes that these cells endure during chronic HF. In addition, he is interested in identifying and devising novel strategies to reverse pathological changes in immune cells in preparation for their transition from the laboratory to the clinic. His training in physiology, immunology, and molecular biology equips him with unique perspectives to research heart failure and develop mechanism-based, clinically applicable immune-therapeutic strategies.
Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, ChinaPathogenesis of diabetes and new targets in diagnosis and treatment; Role of cytokines in the metabolic disorders (NAFLD, obesity; Diabetes and atherosclerosis); Biomarkers in metabolic disorders and cardiovascular diseases; Lifestyle intervention; Gut microbiota and host metabolism
University of Verona | UNIVR · Department of Engineering for Innovation MedicinePre-analytical variability; Analytical and clinical validation of biomarkers; Metabolism of lipoproteins and relevant assay methods; Diagnosis and management of disorders of haemostasis and thrombosis; COVID-19
Department of Preventive Medicine, Department of Dermatology, College of Medicine, The University of Tennessee Health Science Center, 66 N. Pauline Street, Memphis, TN, USACancer prevention; Epidemiology; Melanoma risk factors; Gender difference/gender disparity; Cancer biology
Department of Pharmacology and Toxicology, The University of Arizona, Tucson, United StatesMachine learning; Optimization; Signal processing; Bioinformatics
Dr. Saurav Mallik is currently working as Research Scientist in the Department of Pharmacology and Toxicology, The University of Arizona, USA. Previously, he worked as Postdoctoral Fellow in the Department of Environmental Health, Harvard T H Chan School of Public Health, Boston, USA for more than three years (2019-2022), the Center of Precision Health, Department of School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, Texas, USA for one and half year (2018-2019), and in the Division of Bio-statistics, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA for more than one year (2017-2018). He obtained his PhD degree in the Department of Computer Science & Engineering (C.S.E.) from Jadavpur University, Kolkata, India in 2017 while his PhD works carried out in Machine Intelligence Unit (MIU), Indian Statistical Institute (ISI), Kolkata, India. He worked previously at ISI, Kolkata, India as a Junior Research Fellow (JRF) in DST (Department of Science & Technology, New Delhi, Govt. of India)-sponsored Swarnajayanti project and as a Visiting Scientist (VS) for a total of more than 3 years (2011-2013 & 2015-2016). He also worked in the Department of Computer Science & Engineering, Jadavpur University, Kolkata, India as UGC (University Grant Commission, Govt. of India) Research Fellow for 2 years (2014-2015 & 2016-2017). He is the recipient of Research Associate-ship (RA) from CSIR (Council of Scientific and Industrial Research), MHRD, Govt. of India in 2017. He also worked as assistant professor in the Department of Computer Science & Engineering in Mallabhum Institute of Technology, Bisnupur, WB, India (currently on leave). He is also recipient of "Emerging Researcher In Bioinformatics" award from Bioclues & BIRD Award steering committee, India (http://bioclues.org/) in the year 2020 and "Young scientist award" on “International Scientist Awards on Engineering, Science and Medicine" (ISAO 2021) from a non-profit organization, VDGOOD Professional Association of Scientists, Engineers and Doctors, India in the year 2021. He received two times Travel Grant Award for International Conference on Intelligent Biology and Medicine (ICIBM), June 2018 at Los Angeles, California, USA and August 2021 at Philadelphia, PA, USA. Dr. Mallik has coauthored more than 180 research papers in various peer-reviewed International Journals, Conferences and Book Chapters. He also has more than 20 authored/edited book publication in Taylor & Francis, River publishers, IET, Springer, Bentham, etc. His papers are highly cited (google scholar citation >1850 and h-index=22). He attended many national and international conferences in USA and India. He is currently an active member of Institute of Electrical and Electronics Engineers (IEEE), American Association for Cancer Research (AACR), and Association for Computing Machinery (ACM), USA and life member of BIOCLUES, India (http://bioclues.org/). He is also member of international advisory committee of many reputed engineering colleges in India. His research areas include Data mining, computational biology, bioinformatics, Bio-statistics and machine learning.
Hematology and Transplant University Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, via Venezia 6, 15121, ItalyChronic myeloproliferative neoplasms; Allogeneic hematopoietic stem cell transplantation; Chimeric antigen-receptor T-cells; Immune thrombocytopenia; Venous thromboembolism; Decision analysis; Artificial intelligence; Pharmacoeconomics; Clinical practice guidelines
Neurology department, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaPrognosis of cerebrovascular disease; Rehabilitation treatment of cerebrovascular diseases; Pathogenesis of ischemic stroke
Department of Neurology, Faculty of Medicine, University of São Paulo São Paulo, BrazilNeuroscience; Cognitive Neuroscience; Cognitive Neuropsychology; Brain Imaging; Clinical Neuropsychology; Memory; Executive Function; Learning and Memory; Neuroimaging; Cognition Disorders
Department of Internal Medicine II, University Hospital Salzburg, Paracelsus Medical University, Salzburg, AustriaCardiovascular Disease in COVID-19; Cardiac Arrhythmias; Cardiac Calcium Handling; Mitochondria in Cardiac Pathology; Cardiac Electrophysiology; Cardiac Electrophysiology; Cardiac Biomarkers; Cardiac Device Therapy
Department of Internal Medicine, University of Genova, Genova, ItalyPharmacogenomics; Immunology; Vaccines; Biologics; HIV; Allergies; Atherosclerosis; Autoimmunity; Immune-mediated diseases; Immunodeficiency; Neuroendocrine-immunology
Giuseppe Murdaca has received his PhD in Science and Space Engineering at the University of Genova (Italy) during the period of 2000-2003. Currently, he is working as Assistant professor in Internal Medicine University of Genova (Italy).
His research has included Immunodeficiency Autoimmunity Neuro-endocrino-immunology Pharmacogenomics.
Based on this research and fellowship training he has received several awards and honors, such as:
Prize for young researchers of the study, assigned by the GILS, with the following motivation: "Standardization of a method to assess impairment by skinfold thickness skin", delivered on the occasion of the "Day VII Italian to fight Scleroderma" (Milan, 17/3 / 2001).
Award for one of the three best oral presentations at the Ninth Congress of the Inter-SIMI Piemonte and Valle D'Aosta, Liguria (Genoa, 06.17.2004): Murdaca G., Fenoglio D., M. Setti, Brenci S., Villa R., Pontali E., A. Kunkl, Indiveri F., Puppo F. "Generation of CD4 + lines specific for Pneumocystis carinii and Candida albicans obtained from HIV + patients. Meaning of the coexpression of IFN-? and IL-4 ".
National Institute of Materials Physics, 405A Atomistilor Street, P.O. Box MG7, 077125 Magurele, RomaniaBiomaterials; Biomedical Applications; Biotechnology; Environmental Applications; Food Industry; Hydroxyapatite; Magnetic Properties; Iron Oxide Nanoparticles; Structural Properties; Surface Properties; Antimicrobial Properties; Antimicrobial Coatings; Pharmaceutical Applications; Colloidal Properties
College of Biomedical Sciences, Larkin University, 18301 N Miami Ave, Miami, FL 33169, USAClinical and Translational Research; Drug Discovery and Development; Nanotechnology and Biotechnology; Targeted and Controlled Release Drug Delivery; Bioavailability Enhancement; Crystal Engineering and Ionic Liquids formation of the Drugs; Natural Product Chemistry; Chiral Separations; Surfactant and Colloidal Chemistry; Chemistry of Fragrance
Key laboratory of Chinese internal medicine of Ministry of Education, Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine, Beijing, ChinaEvidence based TCM; Clinical research of TCM; TCM on cardiovascular diseases; Effect characteristics of TCM; Mechanisms of TCM
Computational Biochemistry Research Group, Faculty of Sciences of the University of Porto, Porto, PortugalOrganic Synthesis; Mass Spectrometry; Proteins; Protein Purification; Enzymes; PCR; High-Performance Liquid Chromatography; Protein Expression; Chromatography; SDS-PAGE
Altinbas University, Faculty of Medicine; Bahcelievler Medicalpark Hospital, Istanbul, TurkeyRheumatoid Arthritis; Spondyloarthropathies; Behçet’s Disease; Familial Mediterranean Fever; Sjogren’s Syndrome; Systemic Lupus Erythematosus; Vasculitis; Other automimmune/autoinflammatory rheumatic diseases; COVID-19 immunology and COVID-19 vaccines
Department of Cardiothoracic & Vascular Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, New York, USACardiac surgery; Cardiac regenerative therapy; Tissue engineering; Heart-lung transplantation; Mechanical circulatory support; Regenerative medicine; induced pluripotent stem cell
.jpg){kind=icon}
Department of Pediatrics, University of Louisville School of Medicine, Louisville, USAThe role of SDF-1/CXCR4/CXCR7 axes in diabetic complications;The role of FGFs (e.g.: FGF1, FGF5, FGF16, FGF21, etc.) in diabetic complications; Antioxidative mechanisms of metallothionein and Nrf2 in diabetic complications
Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Rome, Italy3D in dentistry; Aesthetic dentistry; Clinical dentistry; Dental caries; Dental materials; Endodontics; Esthetic dentistry implantology; Oral surgery; Restorative dentistry
1st Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, GreeceNeuropsychiatry; Neuropsychological assessment; Individual traditional and computerized cognitive programs; Cognitive interventions; Motion and art therapy; Physical activity and mental imagery; Reminiscence for Alzheimer’s disease and dementia
She is Professor of Neurology since 2010, Neuropsychiatrist since 1983, and she has worked at Aristotle University of Thessaloniki since 1982 and the 3rd Department of Neurology of Aristotle University of Thessaloniki since 1988. She has been the primary author or co-author for more than 41 Books. She has also, participated with more than 412 abstracts in Greek Conferences, with more than 389 abstracts in English International or European Conferences. She is the first author or co-author in more than 184 paper publications in Greek Journals, and more than 318 in International Journals. Three hundred ninety-three of them are available in her Scopus profile matching an h-index=60, having more than 14000 citations. She has been a reviewer for more than 96 Conferences and Journals. She has organized 27 National Conferences on AD and 6 International. She was one of the three advisory members for 50 doctora theses at the university whom which the 28 are complete. She has created the Greek Alzheimer Association in 1995 and the Greek Federation of Alzheimer.
Department of Research, Fondazione Paolo Procacci, Roma, ItalyPain medicine; Pain assessment; Pain management; Acute pain; Chronic pain; Pain research; Comorbidity; Anesthesiology
President of the World Institute of Pain President, Paolo Procacci Foundation General Manager, ASL Teramo, Public Company of the National Health Care Service President of the European Pain Federation (EFIC) President of Clinicians Council, UNIVAQ Full Professor, Anesthesia and Pain Medicine, UNIVAQ Assoc. Professor of Anesthesia and Pain Medicine, UNIVAQ Chairman, Dept. of Anesthesia, UNIVAQ Invited Professor, Dept. of Anesthesia, University of Barcelona, Spain Invited Professor, Dept. of Anesthesia, University of Massachusetts, Worchester, MA, USA; and University of Tel-Aviv, Israel Assist. Professor of Anesthesia and Pain Medicine, UNIVAQ, L’Aquila, Italy Researcher, University of Roma, Italy Researcher, University of Hamburg, Germany Researcher CNR-NIH, Albert Einstein College of Medicine, Yeshiva University, New York, NY, USA
Obstetrics and Gynecology Unit, IVF Center, DIM Department, University of Bari, Bari, ItalyInfertility; Assisted reproduction technologies; Hysteroscopy; Laparoscopy; Reproductive biology; Reproductive immunology; Ovarian stimulation; Endometrium; Uterine pathologies; Fertility preservation
Cardiovascular Translational Research Center, Department of Cell Biology and Anatomy SmartState Endowed Chair in Biofabrication, University of South Carolina, Columbia, United StatesVascular smooth muscle; Endothelium; Hypertension; Vasculogenic sexual dysfunction (male and female)
Professor, Biomedical Engineerin, 2021-Present
Professor and Chairperson, Department of Physiology Augusta University, 1999-2020
Professor (Assistant to Full), University of Michigan, 1979-99
Research Associate, Universitaire Instelling Antwerpen, 1978-79
Postdoctoral Fellow, University of Michigan, 1976-78
University of Iowa, Ph.D. (Anatomy), 1973-76
Southern Illinois University, M.S. (Physiology), 1971-73
Southern Illinois University, B.A. (Physiology), 1967-71
Heart & Vascular Center Research, Department of Medicine, Biological Sciences Division, The University of Chicago, USACardiac ischemic injury; Sepsis-induced cardiomyopathy (SICM); Diabetic cardiomyopathy; Microvascular endothelial barrier dysfunction; COVID-19-associated heart injury; Cardiac mitochondrial function; Blood-brain-barrier; Cell-cell Communication in the Vascular Diseases
Department of Cardiology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing, ChinaLeft ventricular remodeling; Cardiac regeneration and repair; Inflammation and ischemia reperfusion injury; Stem cell therapy for acute myocardial infarction; Mechanisms of immune regulation
Division of Radiological Sciences, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, United StatesAlzheimer’s disease; Parkinson's disease; Central nervous disorders; Postmortem biomarker validation and characterization; In vivo positron emission tomography; In vitro quantitative autoradiography
Department of Internal of Bashkir State Medical University, Ufa, Russian FederationCardiovascular biomarkers; RIPC; Coronary reperfusion; Arrythmis; COVID-19; Genetics; Epicardial fat; Cardiovascular epidemiology
Pulmonary Department, "General Clinic Euromedica" Private Hospital, Thessaloniki, GreeceLung diseases; Gene therapy; Design, development, and therapy of novel drugs
Dr. Pavlos Zarogoulidis, M.D, Ph. D Director of Pulmonary Department, ``General Clinic Euromedica`` Private Hospital, Thessaloniki, Greece have three MS.c in ``Clinical Pharmacology``, ``Sleep Medicine`` and ``Thyroid Gland Disease and Treatment ``and my Ph. D is regarding inhaled chemotherapy for lung cancer. In my everyday practice I perform diagnosis for lung cancer with bronchoscopy, radial and convex probe endobronchial ultrasound and medical thoracoscopy.
